Matrix therapy offers alternative in treatment of chronic corneal ulcers

PARIS — A matrix regeneration agent offers a new, easy and effective treatment option for chronic corneal ulcers, according to a specialist. The agent, developed and commercialized in Europe by Théa under the name Cacicol, is a mimetic of the heparan sulfates present in the extracellular matrix. “Matrix therapy with Cacicol aims at restoring the matrix architecture and promotes healing processes with instillation of just one drop per day. Results are visible within 10 to 15 days, or 4 weeks in the more complicated cases,” Sihem Lazreg, MD, said at (Read more...)